The Hill
FDA panel recommends mRNA flu vaccine for older adults
A first-of-its-kind flu shot is a step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine…
View original source — The Hill ↗
Related stories
NPR
HealthJun 19, 2026 · 1 min
Key FDA committee unanimously recommends its first vaccine since 2023
NPR
The Guardian
HealthJun 18, 2026 · 1 min
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
The Guardian
Ars Technica
ScienceJun 18, 2026 · 1 min
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
Ars Technica
Straits Times
HealthJun 18, 2026 · 1 min
Moderna's mRNA flu vaccine backed by FDA advisers
Straits Times